Follow Us
https://www.thebody.com/category/non-hiv-stis/tag/news

The Latest

Promo Image

Symposium on Human Papillomavirus (HPV) Infection

The natural history of HPV infection was reviewed as part of a symposium on viral co-infections with HIV. Data from the New York Cervical Disease Study, which has followed both HIV-positive and HIV-negative women since 1991, was presented. They obs...

Promo Image

Gonorrhea Rates Have Increased For The First Time in 13 Years

A study in a recent issue of Morbidity and Mortality Weekly Report (MMWR), published by the U.S. Centers for Disease Control and Prevention (CDC), summarizes the national surveillance data on gonorrhea cases reported to the CDC through state health d...

Promo Image

The Hepatitis Report: A Critical Review of the Research and Treatment of Hepatitis C Virus (HCV) and Hepatitis & HIV Coinfection

Credits and Acknowledgements Dedication Foreword Introduction Epidemiology, Modes of Transmission, & Risk Factors for Hepatitis C Virus Infection Pathogenesis, Viral Dynamics, & Immunologic Response of Hepatitis C Virus Natural History,...

Promo Image

Emergence of Oral HPV Infection Among HIV-Infected Patients in the HAART Era

Emergence of oral HPV infection among HIV-infected patients in the HAART era (TuOrB304) Authored by H.M. Blumberg, M.D. King, C.M. O'Daniels, N.M. Larsen, D. Reznick (United States)

HPV is the virus that causes warts, including genital and ana...

Promo Image

Liver Spot: Progress Is Being Made but Much Remains to Be Done in the Treatment of Hepatitis C Infection

Sexual Transmission Controversy

Michael Marco, TAG's Infections and Oncology Project Director, had his plate full in San Francisco this past February where he doubled up his conference coverage. Along with his dependable insights into the research a...

Promo Image

CRIA Trials in Progress

Chronic Hepatitis C/HIV Co-infection Study CRIA is collaborating with the Hepatitis Resource Network to compare the effectiveness and tolerability of daily interferon and ribavirin vs daily interferon alone for the treatment of chronic hepatitis C in...

Promo Image

Banding Together to Challenge Schering-Plough's Monopoly on Hepatitis C Treatment

The PWA Health Group has been importing ribavirin since the late 1980's, when its potential anti-viral activity against HIV was first being looked into. Ribavirin's promise as an anti-HIV agent didn't pan out; however, over the last few years, studie...

Promo Image

Syringe Exchange and Risk of Infection With Hepatitis B and C Viruses

Abstract:

Research conducted as part of the Risk Activity Variables, Epidemiology, and Network Study of intravenous drug users involved in a Seattle-King County, Wash., needle-exchange program indicates that the program was not effective in reducing...

Promo Image

Hepatitis Treatment Update

Thymosin-Alpha-1 (brand name Zadaxin) has been approved in Mexico as a flu vaccine booster. Hopefully, Mexican approval for the treatment of Hepatitis B and Hepatitis C will follow shortly. Thymosin is an injectable synthetic version of a naturally o...

Promo Image

Evolving Strategies to Attack Hepatitis C

Prior to 1989, what we now characterize as hepatitis C was called either non-A, non-B or transfusion-associated hepatitis. Approximately 4 million Americans are currently infected with HCV, and 8 to 10 thousand Americans die each year due to HCV comp...